Search Results

There are 16185 results for: content related to: Venlafaxine monotherapy in bipolar type II depressed patients unresponsive to prior lithium monotherapy

  1. Establishing bioequivalence of racemic venlafaxine formulations using stereoselective assay method: Is it necessary?


    Volume 23, Issue 10, November 2011, Pages: 948–954, Kirti Kandhwal, Surajit Dey, Shabana Nazarudheen, Simrit Reyar, Sanjeev Mishra, Nageshwar R. Thudi, Arshad H. Khuroo and Tausif Monif

    Version of Record online : 26 SEP 2011, DOI: 10.1002/chir.21021

  2. Changes in cardiovascular function after venlafaxine but not pregabalin in healthy volunteers: a double-blind, placebo-controlled study of orthostatic challenge, blood pressure and heart rate

    Human Psychopharmacology: Clinical and Experimental

    Volume 28, Issue 6, November 2013, Pages: 562–575, Alison Diaper, Ann S. Rich, Sue J. Wilson, Kevin Craig, Colin T. Dourish, Gerry R. Dawson, David J. Nutt and Jayne E. Bailey

    Version of Record online : 16 AUG 2013, DOI: 10.1002/hup.2346

  3. You have free access to this content
    Venlafaxine for neuropathic pain in adults

    Intervention Review

    The Cochrane Library

    Helen C Gallagher, Ruth M Gallagher, Michelle Butler, Donal J Buggy and Martin C Henman

    Published Online : 23 AUG 2015, DOI: 10.1002/14651858.CD011091.pub2

  4. You have free access to this content
    Blockade of 5-Hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine

    British Journal of Pharmacology

    Volume 125, Issue 3, October 1998, Pages: 526–532, Jean-Claude Béïque, Claude de Montigny, Pierre Blier and Guy Debonnel

    Version of Record online : 3 FEB 2009, DOI: 10.1038/sj.bjp.0702074

  5. Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine

    Acta Psychiatrica Scandinavica

    Volume 121, Issue 3, March 2010, Pages: 190–200, J. Wijkstra, H. Burger, W. W. Van Den Broek, T. K. Birkenhäger, J. G. E. Janzing, M. P. M. Boks, J. A. Bruijn, M. L. M. Van Der Loos, L. M. T. Breteler, G. M. G. I. Ramaekers, R. J. Verkes and W. A. Nolen

    Version of Record online : 19 AUG 2009, DOI: 10.1111/j.1600-0447.2009.01464.x

  6. Venlafaxine as the ‘baby ecstasy’? Literature overview and analysis of web-based misusers′ experiences

    Human Psychopharmacology: Clinical and Experimental

    Volume 30, Issue 4, July 2015, Pages: 255–261, Giulia Francesconi, Laura Orsolini, Duccio Papanti, John M. Corkery and Fabrizio Schifano

    Version of Record online : 28 JUL 2015, DOI: 10.1002/hup.2476

  7. Effect of Terbinafine and Voriconazole on the Pharmacokinetics of the Antidepressant Venlafaxine

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 2, February 2008, Pages: 342–348, V-V Hynninen, KT Olkkola, L Bertilsson, K Kurkinen, PJ Neuvonen and K Laine

    Version of Record online : 8 AUG 2007, DOI: 10.1038/sj.clpt.6100311

  8. You have free access to this content
    Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein

    British Journal of Clinical Pharmacology

    Volume 48, Issue 3, September 1999, Pages: 345–354, Abdelmawla, Langley, Szabadi and Bradshaw

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.1999.00031.x

  9. Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans

    Clinical Pharmacology & Therapeutics

    Volume 69, Issue 4, April 2001, Pages: 245–251, Thomas P. Enggaard, Niels A. Klitgaard, Lars F. Gram, Lars Arendt-Nielsen and Søren H. Sindrup

    Version of Record online : 2 APR 2001, DOI: 10.1067/mcp.2001.114873

  10. Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine

    Acta Psychiatrica Scandinavica

    Volume 120, Issue 4, October 2009, Pages: 329–331, M. Koga, F. Kodaka, H. Miyata and K. Nakayama

    Version of Record online : 1 JUL 2009, DOI: 10.1111/j.1600-0447.2009.01433.x

  11. You have free access to this content
    Agomelatine versus other antidepressive agents for major depression

    Intervention Review

    The Cochrane Library

    Giuseppe Guaiana, Sumeet Gupta, Debbie Chiodo, Simon JC Davies, Katja Haederle and Markus Koesters

    Published Online : 17 DEC 2013, DOI: 10.1002/14651858.CD008851.pub2

  12. Extended release of a novel antidepressant, venlafaxine, based on anionic polyamidoamine dendrimers and poly(ethylene glycol)-containing semi-interpenetrating networks

    Journal of Biomedical Materials Research Part A

    Volume 72A, Issue 1, 1 January 2005, Pages: 107–114, Hu Yang and Stephanie T. Lopina

    Version of Record online : 29 NOV 2004, DOI: 10.1002/jbm.a.30220

  13. Achieving remission from depression with venlafaxine and venlafaxine extended release: a literature review of comparative studies with selective serotonin reuptake inhibitors

    Acta Psychiatrica Scandinavica

    Volume 106, Issue s415, December 2002, Pages: 24–30, R. L. Rudolph

    Version of Record online : 19 DEC 2002, DOI: 10.1034/j.1600-0447.106.s415.5.x

  14. You have free access to this content
    Fluoxetine versus other types of pharmacotherapy for depression

    Intervention Review

    The Cochrane Library

    Laura R Magni, Marianna Purgato, Chiara Gastaldon, Davide Papola, Toshi A Furukawa, Andrea Cipriani and Corrado Barbui

    Published Online : 17 JUL 2013, DOI: 10.1002/14651858.CD004185.pub3

  15. Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine

    Biopharmaceutics & Drug Disposition

    Volume 32, Issue 4, May 2011, Pages: 233–244, Corbin J. Bachmeier, David Beaulieu-Abdelahad, Nowell J. Ganey, Michael J. Mullan and Gary M. Levin

    Version of Record online : 28 MAR 2011, DOI: 10.1002/bdd.753

  16. Antidepressants for neuropathic pain

    Intervention Review

    The Cochrane Library

    Tiina Saarto and Philip J Wiffen

    Published Online : 17 OCT 2007, DOI: 10.1002/14651858.CD005454.pub2

  17. You have free access to this content
    A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia

    Journal of Clinical Pharmacy and Therapeutics

    Volume 40, Issue 1, February 2015, Pages: 1–6, L. A. VanderWeide, S. M. Smith and K. E. Trinkley

    Version of Record online : 7 OCT 2014, DOI: 10.1111/jcpt.12216

  18. Effect of Venlafaxine and Desvenlafaxine on Drug Efflux Protein Expression and Biodistribution In Vivo

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 10, October 2013, Pages: 3838–3843, Corbin Bachmeier, Gary M. Levin, David Beaulieu-Abdelahad, Jon Reed and Michael Mullan

    Version of Record online : 29 JUL 2013, DOI: 10.1002/jps.23680

  19. You have free access to this content
    Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997–2007

    Birth Defects Research Part A: Clinical and Molecular Teratology

    Volume 97, Issue 1, January 2013, Pages: 28–35, Kara N. D. Polen, Sonja A. Rasmussen, Tiffany Riehle-Colarusso, Jennita Reefhuis and and the National Birth Defects Prevention Study

    Version of Record online : 26 DEC 2012, DOI: 10.1002/bdra.23096

  20. Venlafaxine-induced ecchymoses and impaired platelet aggregation

    European Journal of Haematology

    Volume 77, Issue 6, December 2006, Pages: 533–537, Anita Sarma and McDonald K. Horne III

    Version of Record online : 29 AUG 2006, DOI: 10.1111/j.0902-4441.2006.t01-1-EJH2919.x